Who is right for TMS Therapy?

Individuals diagnosed with Major Depressive Disorder (single, recurrent, severe) treatment-resistant depression may benefit from TMS Therapy. TMS is considered a second-line agent after one medication trial.

However, insurances typically require 2-3 medication failures in different classes trials and 6 weeks of psychotherapy within the current episode, or otherwise indicated prohibitive medical rationale.

Off label indications for generalized anxiety. OCD and substance use protocols are currently in process.


How to refer?

If you feel your patient may be an appropriate TMS candidate attached a referral letter will help support the authorization process.

Contact us at (503) 433-3200 for more information about TMS therapy.

Cascade TMS will no longer be accepting new patients after October 14, 2022.